Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.
- Resource Type
- Article
- Source
- Molecular Oncology; Aug2017, Vol. 11 Issue 8, p1065-1077, 13p
- Subject
- Language
- ISSN
- 15747891